Hiroyuki Tashimo

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Tezepelumab is effective in older patients with type 2 severe asthma, and baseline serum cytokine levels may be useful in predicting the efficacy of tezepelumab.

Tezepelumab is effective in older patients with type 2 severe asthma, and baseline serum cytokine levels may be useful in predicting the efficacy of tezepelumab.

Journal: The Journal of asthma : official journal of the Association for the Care of Asthma

Published: February 19, 2026

Differences in the efficacies of commonly used asthma questionnaires for predicting asthma-related outcomes among elderly and non-elderly patients in Japan.

Differences in the efficacies of commonly used asthma questionnaires for predicting asthma-related outcomes among elderly and non-elderly patients in Japan.

Journal: The World Allergy Organization journal

Published: March 15, 2025

High Serum Thymic Stromal Lymphopoietin (TSLP) Is Characteristic of Late-Onset, Long-Duration, Eosinophilic Asthma.

High Serum Thymic Stromal Lymphopoietin (TSLP) Is Characteristic of Late-Onset, Long-Duration, Eosinophilic Asthma.

Journal: Allergy

Published: October 07, 2024

Identification of exhaled volatile organic compounds that characterize asthma phenotypes: A J-VOCSA study.

Identification of exhaled volatile organic compounds that characterize asthma phenotypes: A J-VOCSA study.

Journal: Allergology international : official journal of the Japanese Society of Allergology

Published: September 05, 2023

Chronic Pulmonary Aspergillosis Caused by Aspergillus tubingensis Diagnosed by a Bronchoscopic Biopsy.

Chronic Pulmonary Aspergillosis Caused by Aspergillus tubingensis Diagnosed by a Bronchoscopic Biopsy.

Journal: Internal medicine (Tokyo, Japan)

Published: May 31, 2023

Low Serum IL-18 Levels May Predict the Effectiveness of Dupilumab in Severe Asthma.

Low Serum IL-18 Levels May Predict the Effectiveness of Dupilumab in Severe Asthma.

Journal: Internal medicine (Tokyo, Japan)

Published: May 24, 2023

Serum MMP3 and IL1-RA levels may be useful biomarkers for detecting asthma and chronic obstructive pulmonary disease overlap in patients with asthma.

Serum MMP3 and IL1-RA levels may be useful biomarkers for detecting asthma and chronic obstructive pulmonary disease overlap in patients with asthma.

Journal: The World Allergy Organization journal

Published: February 21, 2023

Leptin-producing monocytes in the airway submucosa may contribute to asthma pathogenesis.

Leptin-producing monocytes in the airway submucosa may contribute to asthma pathogenesis.

Journal: Respiratory investigation

Published: March 17, 2022

High serum cytokine levels may predict the responsiveness of patients with severe asthma to benralizumab.

High serum cytokine levels may predict the responsiveness of patients with severe asthma to benralizumab.

Journal: The Journal of asthma : official journal of the Association for the Care of Asthma

Published: June 14, 2021

Corrigendum to "Leptin enhances cytokine/chemokine production by normal lung fibroblasts by binding to leptin receptor" [Allergol Int 68S (2019) S3-S8].

Corrigendum to "Leptin enhances cytokine/chemokine production by normal lung fibroblasts by binding to leptin receptor" [Allergol Int 68S (2019) S3-S8].

Journal: Allergology international : official journal of the Japanese Society of Allergology

Published: May 11, 2021

NEXT-GENERATION ARIA CARE PATHWAYS IN ALLERGIC RHINITIS

NEXT-GENERATION ARIA CARE PATHWAYS IN ALLERGIC RHINITIS

Journal: Arerugi = [Allergy]

Published: September 23, 2020

A Low Serum CCL4/MIP-1β Level May Predict a Severe Asthmatic Responsiveness to Mepolizumab.

A Low Serum CCL4/MIP-1β Level May Predict a Severe Asthmatic Responsiveness to Mepolizumab.

Journal: Internal medicine (Tokyo, Japan)

Published: July 28, 2020

Showing 1-12 of 19

Last Updated: 09/26/2026